Effects of the novel IDO inhibitor DWG-1036 on the behavior of male and female 3xTg-AD mice

E Fertan, KRJ Stover, MG Brant, PM Stafford… - Frontiers in …, 2019 - frontiersin.org
The kynurenine pathway metabolizes tryptophan into nicotinamide adenine dinucleotide,
producing a number of intermediary metabolites, including 3-hydroxy kynurenine and …

Dysregulation of stress systems and nitric oxide signaling underlies neuronal dysfunction in Alzheimer's disease

JG Spiers, HJC Chen, JM Bourgognon… - Free Radical Biology and …, 2019 - Elsevier
Stress is a multimodal response involving the coordination of numerous body systems in
order to maximize the chance of survival. However, long term activation of the stress …

Depression in Alzheimer's disease: an alternative role for selective serotonin reuptake inhibitors?

RJ Elsworthy, S Aldred - Journal of Alzheimer's disease, 2019 - content.iospress.com
Depression is a common co-morbidity seen in people with Alzheimer's disease (AD).
However, the successful treatment of depressive symptoms in people with AD is rarely seen …

Upregulation effects of Tanshinone IIA on the expressions of NeuN, Nissl body, and IκB and downregulation effects on the expressions of GFAP and NF-κB in the brain …

J Li, P Wen, W Li, J Zhou - Neuroreport, 2015 - journals.lww.com
This study aimed to observe the effects of Tanshinone IIA (Tan IIA) treatment on the
expression levels of brain tissue NeuN, Nissl body, IκB, GFAP and NF-κB in Alzheimer's …

[HTML][HTML] Altered functional connectivity of the locus coeruleus in Alzheimer's disease patients with depression symptoms

M Dai, Z Guo, J Chen, H Liu, J Li, M Zhu, J Liu… - Experimental …, 2023 - Elsevier
Studies have shown that functional abnormalities in the locus coeruleus (LC) are strongly
associated with depressive symptoms, but the pattern of LC functional connectivity in …

Imbalance of multiple neurotransmitter pathways leading to depression-like behavior and cognitive dysfunction in the triple transgenic mouse model of Alzheimer …

M Zhang, L Liu, Y Xu, W Wang, N Qiu, F Zhang… - Metabolic Brain …, 2023 - Springer
Depression is among the most frequent psychiatric comorbid conditions in Alzheimer
disease (AD). However, pharmacotherapy for depressive disorders in AD is still a big …

Integrated network pharmacology and comprehensive bioinformatics identifying the mechanisms and molecular targets of yizhiqingxin formula for treatment of …

T Zhang, W Wei, S Chang, N Liu, H Li - Frontiers in pharmacology, 2022 - frontiersin.org
Background: The Yizhiqinxin formula (YZQX) has been used to treat Alzheimer's disease
(AD) or major depression disorder (MDD). However, its specific underlying mechanisms and …

Patchouli alcohol attenuates the cognitive deficits in a transgenic mouse model of Alzheimer's disease via modulating neuropathology and gut microbiota through …

QQ Xu, ZR Su, W Yang, M Zhong, YF Xian… - Journal of …, 2023 - Springer
Background Alzheimer's disease (AD) is a chronic neurodegenerative disease
characterized by progressive cognitive dysfunctions and behavioral impairments. Patchouli …

Tau phosphorylation in female neurodegeneration: role of estrogens, progesterone, and prolactin

D Muñoz-Mayorga, C Guerra-Araiza, L Torner… - Frontiers in …, 2018 - frontiersin.org
Sex differences are important to consider when studying different psychiatric,
neurodevelopmental, and neurodegenerative disorders, including Alzheimer's disease (AD) …

Doença de Alzheimer: estudo da mortalidade no Brasil, 2000-2009

JB Teixeira, PRB Souza Junior, J Higa… - Cadernos de Saúde …, 2015 - SciELO Brasil
A doença de Alzheimer é o tipo de demência que mais prevalece entre os idosos no
mundo. Para avaliar a evolução da mortalidade por doença de Alzheimer no Brasil foi …